Table 2.
An hypothetical country health development governance index
| Sub-functions of health development governance |
Actual Score (A) |
Maximum (B) |
Minimum (C) |
Sub-function Governance Index (D) = (A-C)/(B-C) |
|---|---|---|---|---|
| 1.1 Leadership responsibilities | 20 | 100 | 0 | 0.20 |
| 1.2 National health policy (NHP) | 15 | 100 | 0 | 0.15 |
| 1.3 National health strategic plan (NHSP) | 10 | 100 | 0 | 0.10 |
| 1.4 Dissemination of NHP and NHSP | 40 | 100 | 0 | 0.40 |
| 1.5 Implementation of NHSP | 32 | 100 | 0 | 0.32 |
| 2.1 Existence of health-related legislation | 32 | 100 | 0 | 0.32 |
| 2.2 Enforcement of health-related legislations | 23 | 100 | 0 | 0.23 |
| 3.1 Participation in NHP and NHSP development | 12 | 100 | 0 | 0.12 |
| 3.2 Participation in NHSP implementation | 13 | 100 | 0 | 0.13 |
| 3.3 Participation in tracking of progress | 11 | 100 | 0 | 0.11 |
| 3.4 Responsiveness to communities non-medical expectations | 14 | 100 | 0 | 0.14 |
| 4.1 Intersectoral action | 15 | 100 | 0 | 0.15 |
| 4.2 Public-private partnerships | 16 | 100 | 0 | 0.16 |
| 4.3 Alignment of aid flows to national health development priorities | 17 | 100 | 0 | 0.17 |
| 4.4 Strengthen capacity by coordinated support | 18 | 100 | 0 | 0.18 |
| 4.5 Use of country procurement and public financial management systems | 19 | 100 | 0 | 0.19 |
| 4.6 Strengthen national capacity by avoiding parallel implementation structures | 20 | 100 | 0 | 0.20 |
| 4.7 Aid is more predictable | 21 | 100 | 0 | 0.21 |
| 4.8 Aid is untied | 32 | 100 | 0 | 0.32 |
| 4.9 Shared analysis | 33 | 100 | 0 | 0.33 |
| 4.10 Sufficient integration of global programmes and initiatives into NHSP | 43 | 100 | 0 | 0.43 |
| 5.1 Horizontal equity | 54 | 100 | 0 | 0.54 |
| 5.2 Vertical equity | 65 | 100 | 0 | 0.65 |
| 5.3 Fairness in financial contribution | 55 | 100 | 0 | 0.55 |
| 6.1 Allocative efficiency | 22 | 100 | 0 | 0.22 |
| 6.2 Technical efficiency | 21 | 100 | 0 | 0.21 |
| 6.3 Productivity growth | 25 | 100 | 0 | 0.25 |
| 6.4 Institutionalization of efficiency monitoring | 51 | 100 | 0 | 0.51 |
| 7.1 Existence of transparent results-oriented reporting and assessment frameworks | 52 | 100 | 0 | 0.52 |
| 7.2 Diagnostic reviews | 53 | 100 | 0 | 0.53 |
| 7.3 Use of information from diagnostic reviews | 54 | 100 | 0 | 0.54 |
| 7.4 Publishing of audit reports for public consumption | 61 | 100 | 0 | 0.61 |
| 8.1 National health research systems | 62 | 100 | 0 | 0.62 |
| 8.2 Health knowledge management systems | 62 | 100 | 0 | 0.62 |
| 8.3 Health management information systems | 63 | 100 | 0 | 0.63 |
| 8.4 Information, Communication and Technology Connectivity | 64 | 100 | 0 | 0.64 |
| 9.1 International ethical guidelines for medical practice and health research | 65 | 100 | 0 | 0.65 |
| 9.2 Bioethics review system | 71 | 100 | 0 | 0.71 |
| 9.4 Institutionalization of ethics training | 72 | 100 | 0 | 0.72 |
| 10.1 Link between NEDP, PRSP and NHP/NHSP | 15 | 100 | 0 | 0.15 |
| 10.2 Existence of a MTEF | 20 | 100 | 0 | 0.20 |
| 10.3 Political stability | 10 | 100 | 0 | 0.10 |
| 14.73 | ||||
| OVERALL GOVERNANCE INDEX: | 0.35 | |||